Research

article

Why I Bought and then Sold Celsius This Summer: Celsius Holdings

Sep 13, 2024

The temperature's rising as I've gone from bullish to bearish about Celsius this summer. The experience highlights several behavioral biases we constantly face as investors.

By Simon Erickson

Featured Articles

Article

United Therapeutics is Leading a Biotech Revolution. Here’s Why it…

Sep 4, 2024

First it treated an untreatable disease. Now it's disrupting the entire organ transplant industry. Here's why United Therapeutics needs to be a stock on your radar.

By Simon Erickson

Article

An Upcoming Change for 7investing (Part Deux)

Jul 17, 2024

We have some big news to announce!

By 7investing Team

Article

ASML is About to Have a Monster Year; Upgrading Our…

Jul 2, 2024

The Dutch lithography equipment supplier looks like it'll be very busy in the second half of 2024.

By Simon Erickson

Recent Research

Article

STAAR Surgical’s Q2 Results are Looking Sharp

Sep 18, 2024

The vision correction innovator continues to gain market share on LASIK.

By Simon Erickson

Article

Supermicro’s Selloff is an Opportunity. Here’s Why I’m Buying the…

Aug 29, 2024

Supermicro's stock is up 2,500% during the past 3 years and has now fallen 50% in August. What the heck is going on?

By Simon Erickson

Article

TransMedics’ New “Organs as a Service” Market is Winning the…

Aug 21, 2024

The "organ transplant as a service" market is taking the medical world by storm. How long can the accelerated growth rates continue?

By Simon Erickson

Article

What’s NVIDIA’s Stock Really Worth? Now’s the Right Time to…

Jul 22, 2024

It's a race to develop the world's highest-performance AI accelerators. Will the Computing King continue to wear the AI crown?

By Simon Erickson

Article

Domino’s Pizza: On Sale, But Still Not a Bargain

Jul 18, 2024

The pizza chain's stock went on sale today, though it still doesn't look particularly appetizing.

By Simon Erickson

Article

NIKE: Short-Term Pain, Long-Term Gain?

Jul 16, 2024

Is the global athletic wear king current an excellent investment opportunity?

By Simon Erickson

Article

Cassava Sciences: Is The Fraud Investigation Just Smoke…or an Actual…

Jul 1, 2024

This micro-cap biotech company is working on an innovative cure to Alzheimer's Disease but is surrounded by controversy. Is it worth the risk for investors?

By Simon Erickson